Latest Breaking News On - Baudax bio inc - Page 6 : comparemela.com

Baudax Bio (NASDAQ:BXRX) Issues Quarterly Earnings Results

Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, beating the consensus estimate of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Performance BXRX opened at $0.52 on Friday. The business has a 50-day moving average of $0.69 and a two-hundred […]

Baudax bioWalleye capitalBaudax bio company profileBaudax bio incAlyeska investment groupSusquehanna international groupRenaissance technologiesGet free reportMarketwatch earningsInternational groupBaudax bio dailyNasdaq bxrx

Baudax Bio (NASDAQ:BXRX) Posts Earnings Results, Beats Expectations By $0 55 EPS

Baudax Bio (NASDAQ:BXRX) Posts Earnings Results, Beats Expectations By $0 55 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Baudax bioSusquehanna international groupWalleye capitalBaudax bio incBaudax bio company profileRenaissance technologiesAlyeska investment groupGet free reportMarketwatch earningsBio trading downInternational groupBaudax bio daily

Baudax Bio Announces $1 9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Baudax Bio Announces $1 9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMike moyerBaudax bioExchange commissionBaudax bio incCompany or baudax bio nasdaqBio announcesRegistered direct offering priced at the marketNeuromuscular blocking agentsSecurities actAmended warrantsSeriesx non voting convertible preferred stockNasdaq capital marketRelations contact

Baudax Bio (NASDAQ:BXRX) Posts Earnings Results, Beats Expectations By $0 55 EPS

Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, topping analysts’ consensus estimates of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Down 5.2 % NASDAQ:BXRX traded down $0.03 during midday trading on Thursday, hitting $0.53. The stock had a trading volume […]

Baudax bioWalleye capitalBaudax bio incSusquehanna international groupBaudax bio company profileAlyeska investment groupRenaissance technologiesGet free reportMarketwatch earningsBio stock downBaudax bio dailyNasdaq bxrx

Baudax Bio (BXRX) Announces 2M Share and Warrant Offering at $0 55/sh

Baudax Bio (BXRX) Announces 2M Share and Warrant Offering at $0 55/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBaudax bioExchange commissionBaudax bio incCompany or baudax bio nasdaqNeuromuscular blocking agentsSecurities actAmended warrantsSeriesx non voting convertible preferred stockNasdaq capital marketRelations contact